이상반응 보고
| VAERS ID | 2001802 |
|---|---|
| 성별 | 남성 |
| 나이 | 49세 |
| 주 코드 | TX |
| 제약회사 | MODERNA |
| 로트 번호 | 017B21A |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-04-09 |
| 발병일 | 2021-12-04 |
| 상태 | 입원 사망 |
증상
- 부적절한 제품 관리 일정(Inappropriate schedule of product administration)
- 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
- 기관 삽관(Endotracheal intubation)
- 코로나19 폐렴(COVID-19 pneumonia)
- 호흡부전(Respiratory failure)
- 죽음(Death)
- 충격(Shock)
- 항응고 요법(Anticoagulant therapy)
- 호흡기 장애(Respiratory disorder)
- 폐렴 세균(Pneumonia bacterial)
이환 중 질병
지병
Coronary artery disease, Combined systolic and diastolic congestive heart failure, COPD, Diabetes mellitus, cardiac stent, Hyperlipidemia, Hypertension, Hypothyroidism, Myocardial infarction, Obesity, Seasonal allergies, obstructive sleep apnea, history of hodgkins disease
기타 의료
Aspirin 81 mg daily, atorvastatin 80 mg daily, B-complex with vitamin C tablet daily, calcium-vitamin D 500 mg-200 mg tablet daily, co-enzyme Q-10 30 mg daily, colchicine 0.6 mg daily, folic ac/vit Bcomp,C/Zn/vit D3 (FA-VIT BCOMP-C-ZINC-V
이전 예방접종
알레르기
Rosuvastatin
임상 검사
증상 상세
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death.
Patient received Moderna Vaccines on 3/12/21 and 4/9/21.
Admitted to Hospital on 12/4/21.
On 12/9/21 intubated and transferred to another hospital for respiratory failure due to COVID-19 PNA.
PMHx HTN, Hodgkin's lymphoma, COPD, combined systolic & diastolic CHF.
Developed secondary bacterial PNA and shock.
Respiratory status cont'd to decline.
Tx'd w/dexamethasone, pressors, broad spectrum antibiotics and therapeutic anticoagulation.
Expired 12/19/2021.